Cargando…

Liver injury caused by SARS-CoV-2 Delta and Omicron-variant in Taiwan

Detalles Bibliográficos
Autor principal:	Jang, Tyng-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Formosan Medical Association. Published by Elsevier Taiwan LLC. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212798/ https://www.ncbi.nlm.nih.gov/pubmed/35750563 http://dx.doi.org/10.1016/j.jfma.2022.06.004

Ejemplares similares

Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2
por: Antonelli, Michela, et al.
Publicado: (2022)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa
por: Goga, Ameena, et al.
Publicado: (2022)

Hospitalisation associated with SARS-CoV-2 delta variant in Denmark
por: Bager, Peter, et al.
Publicado: (2021)

SARS-CoV-2 antigen-detecting rapid tests for the delta variant
por: Bekliz, Meriem, et al.
Publicado: (2022)

T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant
por: Choi, Seong Jin, et al.
Publicado: (2022)

Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant
por: Zhang, Wei, et al.
Publicado: (2022)

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
por: Altarawneh, Heba N., et al.
Publicado: (2022)

Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
por: Yu, Jingyou, et al.
Publicado: (2022)

Increased immune escape of the new SARS-CoV-2 variant of concern Omicron
por: Hu, Jie, et al.
Publicado: (2022)

Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients
por: Destras, Grégory, et al.
Publicado: (2022)

Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant
por: Yamasoba, Daichi, et al.
Publicado: (2023)

Comparison of the causes of death associated with delta and Omicron SARS-CoV-2 variants infection
por: Kim, A Reum, et al.
Publicado: (2023)

Clinical characteristics and treatment outcomes of SARS-CoV-2 delta variant outbreak, Pingtung, Taiwan, June 2021
por: Jang, Tyng-Yuan, et al.
Publicado: (2022)

Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use
por: Rockett, Rebecca, et al.
Publicado: (2022)

SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
por: Bojkova, Denisa, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons
por: Rössler, Annika, et al.
Publicado: (2022)

Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2
por: Shen, Yaping, et al.
Publicado: (2022)

SARS-CoV-2 variant omicron XBB.1.5: challenges and prospects – correspondence
por: Channabasappa, Nikhil K., et al.
Publicado: (2023)

Dynamic disease manifestations among individuals infected with SARS-CoV-2 Omicron variant
por: Wang, Peiqin, et al.
Publicado: (2023)

Evaluation of immune evasion in SARS-CoV-2 Delta and Omicron variants
por: Chaudhari, Armi M., et al.
Publicado: (2022)

Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination
por: Yu, Xiaoqi, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
por: Pajon, Rolando, et al.
Publicado: (2022)

Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
por: Duong, Bao V., et al.
Publicado: (2022)

Proteomic characterization of Omicron SARS-CoV-2 host response
por: Bao, Jianfeng, et al.
Publicado: (2022)

Severity of SARS-CoV-2 Omicron XBB subvariants in Singapore
por: Pung, Rachael, et al.
Publicado: (2023)

Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report
por: Blennow, Ola, et al.
Publicado: (2022)

Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant
por: Uriu, Keiya, et al.
Publicado: (2023)

Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1
por: Miller, Jessica, et al.
Publicado: (2023)

More data needed on efficacy and safety of monovalent vaccines against SARS-CoV-2 omicron variants
por: Monach, Paul A, et al.
Publicado: (2023)

Identification of Entry Inhibitors against Delta and Omicron Variants of SARS-CoV-2
por: Lee, Richard Kuan-Lin, et al.
Publicado: (2022)

Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron
por: Dong, Rui, et al.
Publicado: (2022)

COVID‐19 severity from Omicron and Delta SARS‐CoV‐2 variants
por: Wrenn, Jesse O., et al.
Publicado: (2022)

Antibody Response after SARS-CoV-2 Infection with the Delta and Omicron Variant
por: Błaszczuk, Agata, et al.
Publicado: (2022)

Vaccine Effect on Household Transmission of Omicron and Delta SARS-CoV-2 Variants
por: Kim, Yong Chan, et al.
Publicado: (2022)

Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2
por: Ward, Thomas, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Replacement of Delta as Predominant Variant, Puerto Rico
por: Santiago, Gilberto A., et al.
Publicado: (2023)

2298. Penetration of SARS-CoV-2 Alpha, Delta, and Omicron Variants in the USA
por: Choi, Hosoon, et al.
Publicado: (2023)

Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance
por: Rockett, Rebecca J., et al.
Publicado: (2022)

T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals
por: Jordan, Stanley C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bjvtlbfqfusmlmifi1ocnn32u4